Pro-atherosclerotic markers and cardiovascular risk factors one year after liver transplantation

Table 2 Demographic and clinical characteristics of the studied population

Variable (mean ± SEM) otherwise indicated	NASH (n = 22)	LT (n = 44)	Controls (n = 20)	P1
Age	58.5 ± 6.511	50.8 ± 14.3	51.2 ± 9.31	< 0.001
Sex %male/female	36.3/63.7	65.9/34.1	53.4/46.7
BMI	31.7 ± 4.351	24.3 ± 4.3	25.1 ± 2.7	< 0.001
Fasting glucose	139.7 ± 60.6	118.1 ± 46.8	NA	< 0.001
Fasting insulin	17.6 ± 8.68	12.15 ± 7.7	NA	0.03
HOMA-IR	6.173 ± 6.68	3.43 ± 2.4	NA	< 0.001
AST	45.5 ± 28.5	23 ± 18.1	NA	0.002
ALT	58.8 ± 45.5	23 ± 15.3	NA	< 0.001
Total cholesterol	199.5 ± 44.3	171.27 ± 26.8	NA	NS
HDL cholesterol	50.1 ± 12.3	49.6 ± 15.9	NA	NS

¹LT vs NASH. SEM: Standard error of the mean; NS: Non-significant; NA: Not applied; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; HDL: High-density lipoprotein.